← Back to directory

Simon T. Barry

Researcher Next ID · RN-036924

Researcher · Biochemistry, Genetics and Molecular Biology

AstraZeneca (United Kingdom)

Cambridge, Singapore

Accepting doctoral researchersFunding unknown
Works count
586
Citation count
14,580
H-index
60
i10-index
134

Research interests

Biochemistry, Genetics and Molecular Biology
Computer Science
Immunology and Microbiology
Medicine
PI3K/AKT/mTOR signaling in cancer
Computational Drug Discovery Methods
Immune cells in cancer
Angiogenesis and VEGF in Cancer
Cancer Immunotherapy and Biomarkers

Publications

  • Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

    Nature Medicine · 2024 · 10.1038/s41591-024-02808-y

  • Therapeutic targeting of tumour myeloid cells

    Nature reviews. Cancer · 2023 · https://doi.org/10.1038/s41568-022-00546-2

  • CXCR2 inhibition enables NASH-HCC immunotherapy

    Gut · 2022 · 10.1136/gutjnl-2021-326259

  • The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

    Nature Genetics · 2021 · https://doi.org/10.1038/s41588-020-00753-3

  • HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

    Cell Reports · 2020 · 10.1016/j.celrep.2020.107625

  • MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects

    Nature Immunology · 2020 · 10.1038/s41590-020-00818-9

  • Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

    Gastroenterology · 2020 · 10.1053/j.gastro.2020.09.043

  • Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer

    Cell Reports · 2019 · 10.1016/j.celrep.2019.07.068

  • Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis

    Cancer Cell · 2019 · https://doi.org/10.1016/j.ccell.2019.08.003

  • Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival

    Cancer Discovery · 2018 · 10.1158/2159-8290.cd-18-0389

  • TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence

    Science Translational Medicine · 2018 · 10.1126/scitranslmed.aan1230

  • CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype

    Cell Reports · 2018 · 10.1016/j.celrep.2018.03.131

  • IL-23 secreted by myeloid cells drives castration-resistant prostate cancer

    Nature · 2018 · https://doi.org/10.1038/s41586-018-0266-0

  • Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo

    Science Translational Medicine · 2016 · 10.1126/scitranslmed.aad2355

  • Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

    Advanced Drug Delivery Reviews · 2016 · https://doi.org/10.1016/j.addr.2016.04.025

  • CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma

    Cancer Cell · 2016 · https://doi.org/10.1016/j.ccell.2016.04.014

  • WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited

    Journal of Clinical Investigation · 2015 · 10.1172/jci76452

  • Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

    JNCI Journal of the National Cancer Institute · 2014 · 10.1093/jnci/dju169

  • Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

    Cancer Research · 2013 · https://doi.org/10.1158/0008-5472.can-12-4561

  • Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy

    Clinical Cancer Research · 2013 · 10.1158/1078-0432.ccr-13-1637

  • AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

    Cancer Research · 2005 · https://doi.org/10.1158/0008-5472.can-04-4409

  • PDGF-regulated rab4-dependent recycling of αvβ3 integrin from early endosomes is necessary for cell adhesion and spreading

    Current Biology · 2001 · 10.1016/s0960-9822(01)00442-0

  • ARF1 Mediates Paxillin Recruitment to Focal Adhesions and Potentiates Rho-stimulated Stress Fiber Formation in Intact and Permeabilized Swiss 3T3 Fibroblasts

    The Journal of Cell Biology · 1998 · 10.1083/jcb.143.7.1981

  • Acidic phospholipids inhibit the intramolecular association between the N- and C-terminal regions of vinculin, exposing actin-binding and protein kinase C phosphorylation sites

    Biochemical Journal · 1996 · 10.1042/bj3140827

  • The RhoA-dependent assembly of focal adhesions in Swiss 3T3 cells is associated with increased tyrosine phosphorylation and the recruitment of both pp125FAK and protein kinase C-δ to focal adhesions

    Journal of Cell Science · 1994 · 10.1242/jcs.107.7.2033

Current projects

    No projects listed.